Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Vomiting 1Radiation Injuries 1Nausea 1

Interventions

Radiotherapy 15Cisplatin 6Amifostine 5Radiotherapy, Intensity-Modulated 4sargramostim 3Radiation 3Paclitaxel 3Bevacizumab 3Surgical Procedures, Operative 2Chemotherapy, Adjuvant 2Carboplatin 2cevimeline 1beta Carotene 1alpha-Tocopherol 1Zinc Sulfate 1Xylitol 1Vortioxetine 1Tooth Extraction 1Steroids 1Selenomethionine 1Salts 1Saline Solution 1Radiotherapy, Conformal 1Radiography, Panoramic 1Radiation Protection 1Physical Therapy Modalities 1Palonosetron 1Oral Hygiene 1Olanzapine 1Neck Dissection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Radiation Injuries × Olanzapine × Head & Neck × Clear all
NCT05202275 2022-01-21

The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs

ChineseAMS

Phase 2 Unknown
43 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nausea, Radiation Injuries, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡